v3.21.1
Condensed Consolidated Statements of Shareholders' Equity and Convertible Preferred Shares - USD ($)
$ in Thousands
Common Shares
Pre-funded warrants
Additional paid-in capital
Cumulative translation adjustment
Accumulated deficit
Total
Opening balance at Dec. 31, 2019 $ 226,245   $ 3,805 $ (1,634) $ (113,499) $ 114,917
Balance at the beginning of period (in shares) at Dec. 31, 2019 24,505,748          
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Net loss and comprehensive loss         (16,343) (16,343)
Exercise of stock options (note 5) $ 133   (56)     77
Exercise of stock options (note 5) (in shares) 53,722          
Share-based compensation (note 5)     981     981
Closing balance at Mar. 31, 2020 $ 226,378   4,730 (1,634) (129,842) $ 99,632
Balance at the end of period (in shares) at Mar. 31, 2020 24,559,470          
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Number of warrants   11,417,034       11,417,034
Opening balance at Dec. 31, 2020 $ 251,682 $ 48,007 8,530 (1,634) (163,466) $ 143,119
Balance at the beginning of period (in shares) at Dec. 31, 2020 29,827,997         29,827,997
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Net loss and comprehensive loss         (12,514) $ (12,514)
Exercise of stock options (note 5) $ 34   (15)     19
Exercise of stock options (note 5) (in shares) 18,003          
Share-based compensation (note 5)     1,368     1,368
Closing balance at Mar. 31, 2021 $ 251,716 $ 48,007 $ 9,883 $ (1,634) $ (175,980) $ 131,992
Balance at the end of period (in shares) at Mar. 31, 2021 29,846,000         29,846,000
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Number of warrants   11,417,034       11,417,034